Market Closed - Nasdaq Other stock markets | 5-day change | 1st Jan Change | ||
10.39 USD | -0.86% | +1.86% | -60.21% |
Aug. 19 | Walgreens Announces Executive Appointments | CI |
Aug. 19 | Cencora's cure-all: A dose of data and distribution |
Valuation: Walgreens Boots Alliance, Inc.
(USD)
Capitalization | 9.26B | P/E ratio 2024 * | -1.25x | P/E ratio 2025 * | 13.1x |
---|---|---|---|---|---|
Enterprise value | 16.62B | EV / Sales 2024 * | 0.11x | EV / Sales 2025 * | 0.11x |
Free-Float | 60.8% | Yield 2024 * | 12.2% | Yield 2025 * | 9.63% |
More valuation ratios * Estimated data
Chart: Walgreens Boots Alliance, Inc.
Dynamic Chart
Latest news: Walgreens Boots Alliance, Inc.
Walgreens Announces Executive Appointments | CI | |
Cencora's cure-all: A dose of data and distribution | ||
Walgreens Collaborating With US Drug Research Authority to Boost Clinical Trials | MT | |
Harris' anti-price gouging plan could build on US state law | RE | |
Walgreens Boots Alliance Prices $750 Million Notes Offering | MT | |
Global markets live: Amazon, Intel, Boeing, Robinhood, KKR, Zillow... | ||
Nasdaq's wild mood swings | ||
Walgreens explores options for selling VillageMD business | RE | |
Walgreens Mulls Sale of VillageMD | DJ | |
Walgreens, Instacart Partner to Accept Online Snap/EBT Payments | MT | |
Walgreens Plans to Sell Another Slice of Its Cencora Stake for $1.1 Billion | CI | |
Global markets live: Wells Fargo, Nintendo, Apple, Amazon, Alphabet... | ||
Sector Update: Health Care Stocks Decline Premarket Friday | MT |
More news
Last Transcript: Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., Q3 2024 Earnings Call, Jun 27, 2024
More transcripts
Analysts' recommendations: Walgreens Boots Alliance, Inc.
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11 | MT | |
ANALYST RECOMMENDATIONS : Sirius Xm, Tesla, Chipotle, Spotify, Walgreens Boots... | ||
Barclays Adjusts Price Target on Walgreens Boots Alliance to $7 From $11 | MT | |
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target is $13.70 | MT | |
UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating | MT |
More recommendations
Press Releases: Walgreens Boots Alliance, Inc.
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit | PR | |
PR | ||
Walgreens Boots Alliance, Inc. Sued for Securities Law Violations - Contact The Rosen Law Firm Before September 10, 2024 to Discuss Your Rights - WBA | PR | |
Walgreens Appoints Two New Leaders to its Retail and Customer Experience Team | AQ | |
Walgreens and BARDA Form Strategic Partnership to Strengthen Decentralized Clinical Trials Model and Reporting | BU |
More press releases
News in other languages: Walgreens Boots Alliance, Inc.
Cencora, Inc.: Una dosis de datos y distribución | ||
EE.UU. - Valores a seguir en Wall Street (actualizado) | ||
Wall Street se prend les pieds dans le rebond | ||
En Direct des Marchés : Sanofi, VusionGroup, KBC, Sandoz, Rheinmetall, Zillow... | ||
Borsa di Italia: Wall Street in stallo nel rimbalzo |
More news
Quotes and Performance
1 day | -0.86% | ||
1 week | +1.86% | ||
Current month | -12.47% | ||
1 month | -5.63% | ||
3 months | -41.69% | ||
6 months | -53.43% | ||
Current year | -60.21% |
More quotes
Course Extremes
1 week
10.20
11.14
1 month
10.19
12.29
Current year
10.19
27.05
1 year
3 years
10.19
55.00
5 years
10.19
64.50
10 years
10.19
97.30
More quotes
Managers and Directors: Walgreens Boots Alliance, Inc.
Director | Title | Age | Since |
---|---|---|---|
Manmohan Mahajan DFI | Director of Finance/CFO | 45 | 16-01-31 |
Ornella Barra COO | Chief Operating Officer | 69 | 14-11-30 |
Anita M. Allemand PRN | Corporate Officer/Principal | - | 21-10-28 |
Manager | Title | Age | Since |
---|---|---|---|
Stefano Pessina CHM | Chairman | 83 | 12-07-31 |
Jan Babiak BRD | Director/Board Member | 66 | 12-03-31 |
Nancy Schlichting BRD | Director/Board Member | 69 | 06-09-30 |
More insiders
Other Drug Retailers
Add to a list Add to a list 0 selected To use this feature you must be a member Log inSign up | Change | 5d. change | 1-year change | 3-years change | Capi. ($) | |
---|---|---|---|---|---|---|
WALGREENS BOOTS ALLIANCE, INC. | -0.86% | +1.86% | -60.70% | -78.15% | 9.26B | |
JD HEALTH INTERNATIONAL INC. | -2.95% | +1.66% | -48.18% | -68.46% | 9.03B | |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | 0.00% | -7.10% | -29.67% | -73.83% | 6.21B | |
+0.11% | -3.31% | -25.60% | +33.34% | 6.06B | ||
CORPORATIVO FRAGUA, S.A.B. DE C.V. | +0.04% | +5.03% | +105.33% | +197.91% | 5.24B | |
CLICKS GROUP LIMITED | -0.15% | +1.05% | +30.98% | +20.82% | 4.74B | |
NAHDI MEDICAL COMPANY | -0.90% | +5.24% | -14.23% | - | 4.64B | |
YIFENG PHARMACY CHAIN CO., LTD. | -1.57% | -10.91% | -38.64% | -42.89% | 3.23B | |
REDCARE PHARMACY NV | -0.83% | -5.40% | +26.32% | -3.66% | 2.99B | |
WELCIA HOLDINGS CO., LTD. | +0.55% | +1.84% | -23.63% | -50.45% | 2.82B | |
Average | -0.66% | -0.22% | -7.80% | -7.26% | 5.42B | |
Weighted average by Cap. | -0.82% | +0.52% | -15.06% | -15.21% |
See all sector performances
Financials
(USD)
2024 * | 2025 * | |
---|---|---|
Net sales | 146B | 148B |
Net income | -6.94B | 770M |
Net Debt | 7.36B | 6.71B |
More financial data * Estimated data
Company Profile
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Employees
268,500
Sector
Drug Retailers
Calendar
2024-10-09 - Q4 2024 Earnings Release (Projected)
Related indices
More about the company
Quotes
Date | Price | Change | Volume |
---|---|---|---|
24-08-21 | 10.39 $ | -3.17% | 15,821,110 |
24-08-20 | 10.73 $ | -1.11% | 12,712,372 |
24-08-19 | 10.85 $ | -0.64% | 12,516,563 |
24-08-16 | 10.92 $ | +0.92% | 11,044,161 |
24-08-15 | 10.82 $ | +3.74% | 9,061,912 |
Delayed Quote Nasdaq, August 21, 2024 at 04:00 pm EDT
More quotes
Income Statement and Estimates
More financial data
Analysis / Opinion
More Strategies
Ratings
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
10.73USD
Average target price
13.62USD
Spread / Average Target
+26.93%
Consensus
Profit revisions
Estimate revisions
Quarterly earnings, Rate of surprise
Company calendar
- Stock Market
- Equities
- WBA Stock